JollyRoger
Senior Member
- Messages
- 138
Hi,
I found a new study about immunoadsorption for Long COVID sufferers.
Unfortunately, its in German.
The English article will be available in two weeks according to the website.
https://www.aerzteblatt.de/archiv/2...s-Fatigue-dominanten-Long-Post-COVID-Syndroms
The article basically says that the treatment removed all the relevant autoantibodies in ten patients (GPCR-AAK like beta1 and beta2).
They suffered from Long covid for about 24,5 months.
There was a very slight and irrelevant improvement.
Overall, it seems unlikely that these autoantibodies are the cause of the problem.
It rather seems to be an epiphenomenon.
There could be autoantibodies which are still attached to the Membran of the receptors, though.
The results are disappointing but its important to know because some people spend a lot of money for this treatment (at least in Germany).
I found a new study about immunoadsorption for Long COVID sufferers.
Unfortunately, its in German.
The English article will be available in two weeks according to the website.
https://www.aerzteblatt.de/archiv/2...s-Fatigue-dominanten-Long-Post-COVID-Syndroms
The article basically says that the treatment removed all the relevant autoantibodies in ten patients (GPCR-AAK like beta1 and beta2).
They suffered from Long covid for about 24,5 months.
There was a very slight and irrelevant improvement.
Overall, it seems unlikely that these autoantibodies are the cause of the problem.
It rather seems to be an epiphenomenon.
There could be autoantibodies which are still attached to the Membran of the receptors, though.
The results are disappointing but its important to know because some people spend a lot of money for this treatment (at least in Germany).
Attachments
Last edited: